TMC114/TMC41629
Showing 1 - 25 of 89
Healthy Trial in Edegem (DRV/COBI FDC, COBI, DRV)
Completed
- Healthy
- DRV/COBI FDC
- +2 more
-
Edegem, BelgiumSGS Belgium NV
Oct 25, 2022
HIV-1 Infections Trial in Worldwide (Darunavir, Ritonavir)
Completed
- HIV-1 Infections
-
Rio De Janeiro, Brazil
- +16 more
Oct 6, 2022
Human Immunodeficiency Virus (HIV) Trial in South Africa, Spain, United States (DRV/COBI FDC)
Recruiting
- Human Immunodeficiency Virus (HIV)
- DRV/COBI FDC
-
Atlanta, Georgia
- +5 more
Aug 2, 2022
Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir
Completed
- Healthy
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
- +3 more
-
Groningen, NetherlandsPRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Aug 3, 2021
Healthy Trial in Groningen (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC, Darunavir, Emtricitabine/Tenofovir
Terminated
- Healthy
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC
- +3 more
-
Groningen, NetherlandsPRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Jul 3, 2020
Antiretroviral Agents in HIV-infected Pregnant Women.
Recruiting
- HIV Infections
-
Brussels, Belgium
- +20 more
Nov 28, 2022
Virologic Response in Participants Newly Diagnosed With HIV-1
Completed
- HIV
- Antiretroviral Therapy
-
Lisboa, PortugalChlo - Hosp. Egas Moniz
Jan 17, 2023
Post-Acute COVID-19 Syndrome Trial in Houston (Stem Cell)
Not yet recruiting
- Post-Acute COVID-19 Syndrome
- Stem Cell
-
Houston, TexasThe University of Texas Health Science Center at Houston
Nov 29, 2023
Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)
Recruiting
- Tuberous Sclerosis
- Lymphangioleiomyomatosis
- Phlebotomy
- +3 more
-
Birmingham, Alabama
- +22 more
Jan 6, 2023
Healthy Trial in Merksem (Dabigatran Etexilate, DRV/COBI, Ritonavir)
Completed
- Healthy
- Dabigatran Etexilate
- +3 more
-
Merksem, BelgiumClinical Pharmacology Unit
Jun 8, 2021
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)
Terminated
- Human Immunodeficiency Virus
-
Oakland Park, FloridaMidland Research Group, Inc
Dec 3, 2021
HIV-1 Trial in Spain, United States (D/C/F/TAF FDC )
Completed
- HIV-1
- D/C/F/TAF FDC placebo
-
Phoenix, Arizona
- +7 more
Jul 1, 2021
Candida Vulvovaginitis Trial in United States (Ibrexafungerp, Placebo)
External Anogenital Warts Trial in Russian Federation, Ukraine, United States (Podofilox Gel 0.5%, Condylox Topical Gel 0.5%,
Completed
- External Anogenital Warts
- Podofilox Gel 0.5%
- +2 more
-
Miami, Florida
- +16 more
Jul 7, 2021
Healthy Trial in Fukuoka (Darunavir/Cobicistat)
Completed
- Healthy
-
Fukuoka, JapanSouseikai Hakata Clinic
May 15, 2018
Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and
Completed
- Human Immunodeficiency Virus (HIV)
- D/C/F/TAF Fixed-Dose Combination (FDC)
-
Bergamo, Italy
- +17 more
Nov 24, 2020
Cocaine Dependence Trial in Houston (Citalopram, Placebo)
Completed
- Cocaine Dependence
- Citalopram
- Placebo
-
Houston, TexasUT-Houston Behavioral and Biomedical Sciences Building
Aug 29, 2020
Human Immunodeficiency Virus Infection Trial in Sacramento (darunavir with ritonavir and fixed-dose viread+emtricitabine daily)
Completed
- Human Immunodeficiency Virus Infection
- darunavir with ritonavir and fixed-dose viread+emtricitabine daily
-
Sacramento, CaliforniaUniversity of California Davis
Feb 24, 2020
Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))
Forehead Rhytides, Forehead Wrinkles Trial in Houston (Botulinum toxin type A, 2.5% lidocaine/2.5% prilocaine, petrolatum
Completed
- Forehead Rhytides
- Forehead Wrinkles
- Botulinum toxin type A
- +2 more
-
Houston, TexasRobert Cizik Eye Clinic
Jun 1, 2020
HIV-1 Trial in United States (DRV/COBI FDC tablet, D/C/F/TAF FDC tablets)
Completed
- HIV-1
- DRV/COBI FDC placebo tablet
- D/C/F/TAF FDC placebo tablets
-
Phoenix, Arizona
- +3 more
May 9, 2019